Latest News
HR3630: Lymphedema Treatment Act
20411
wp-singular,page-template-default,page,page-id-20411,wp-theme-bridge,bridge-core-2.5.2,ajax_fade,page_not_loaded,,qode_grid_1400,side_menu_slide_from_right,qode-theme-ver-23.7,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-6.4.1,vc_responsive
 
HR3630
Lymphedema Treatment Act
1
Roll Calls
286
Yea (latest vote)
7
Nay (latest vote)
House
2022-11-17 – 2022-11-17

About HR3630

Lymphedema Treatment Act

Policy Area: Health

Sponsor: Rep. Schakowsky, Janice D. [D-IL-9] (D-IL)

Latest Action (2022-11-17): Received in the Senate and Read twice and referred to the Committee on Finance.

Summary

Lymphedema Treatment Act This bill provides for Medicare coverage of lymphedema compression treatment items. Specifically, the bill provides for coverage of standard and custom fitted gradient compression garments and other approved items that are prescribed by a physician or other specified health care professional to treat lymphedema.

Subjects: Cardiovascular and respiratory health, Health care coverage and access, Immunology and vaccination, Medicare

Who Voted How on HR3630

Filter by Yea, Nay, or Absent

Vote Breakdown — HR3630

How members voted on HR3630. 0 total positions across all roll calls for this bill.

No vote data available for HR3630.

Other Contested Bills